文献速递生殖医学

玻璃化冷冻与慢速冷冻胚胎后单胎围产结局:基于倾向性评分分析的多中心队列研究

Perinatal outcomes of singletons following vitrification versus slow-freezing of embryos: a multicenter cohort study using propensity score analysis.
PubMed 文献 · Hum Reprod · 2019-01-01

该多中心回顾性队列研究纳入2011年1月至2015年12月中国广东6家生殖医学中心3199例第3天冷冻胚胎移植后活产单胎,经倾向性评分1:1匹配后比较玻璃化冷冻与慢速冷冻组的围产结局;匹配后297对新生儿中,两组早产、低出生体重、巨大儿、小于胎龄儿和大于胎龄儿发生率均无显著差异,玻璃化冷冻未增加上述不良围产结局风险。

要点

  • 匹配后297对新生儿中,玻璃化冷冻组与慢速冷冻组早产、低出生体重、巨大儿、小于胎龄儿和大于胎龄儿发生率均无显著差异。
  • 多因素回归显示玻璃化冷冻在早产、低出生体重、巨大儿、小于胎龄儿和大于胎龄儿发生上均不劣于慢速冷冻(P>0.05)。
  • 性别分层倾向性评分匹配模型进一步显示,玻璃化冷冻在男婴和女婴队列中均未增加上述不良围产结局风险。

核心结论

  • 与慢速冷冻胚胎移植相比,玻璃化冷冻胚胎移植未增加不良新生儿结局风险。
  • 鉴于玻璃化冷冻在活产率上的优势和围产安全性的不劣效性,从慢速冷冻转向玻璃化冷冻进行胚胎冷冻保存是令人安心的。
  • 未来仍需研究玻璃化冷冻方法对子代健康结局的长期影响。

研究设计与样本

  • 中国东南部广东省6家大型生殖医学中心参与的多中心回顾性队列研究。
  • 纳入2011年1月至2015年12月间第3天冷冻复苏胚胎移植周期后活产单胎3199例,每位患者每队列仅贡献一个周期,排除消失双胎。
  • 采用倾向性评分匹配以控制潜在混杂因素,匹配比例为1:1。
  • 匹配变量包括基线人口学特征(母亲年龄、BMI、教育水平、产次、不孕类型和不孕原因)以及IVF特征(授精方式、内膜准备方案和胚胎冷冻保存时长)。
  • 玻璃化胚胎移植组2858例,慢速冷冻组341例婴儿;倾向性评分匹配后生成297对新生儿进行比较。

主要发现

  • 两组中位 gestational age 均为39周,出生体重相当(玻璃化冷冻组3187.7 ± 502.1 g vs 慢速冷冻组3224.6 ± 483.6 g,P>0.05)。
  • 两组早产发生率5.4% vs 7.7%,低出生体重6.7% vs 5.7%,巨大儿5.7% vs 6.1%,小于胎龄儿12.5% vs 8.4%,大于胎龄儿6.4% vs 8.1%,均无显著差异。
  • 平行logistic回归分析显示玻璃化冷冻在早产(OR 0.68 [95% CI 0.35, 1.31])、低出生体重(OR 1.19 [95% CI 0.61, 2.32])、巨大儿(OR 0.94 [95% CI 0.48, 1.86])、小于胎龄儿(OR 1.55 [95% CI 0.91, 2.64])和大于胎龄儿(OR 0.78 [95% CI 0.42, 1.45])发生上不劣于慢速冷冻,P>0.05。
  • 性别分层倾向性评分匹配模型结合多因素回归分析进一步证实,玻璃化冷冻在男婴或女婴队列中均未增加上述不良围产结局风险。

临床怎么用

  • 作者认为,玻璃化胚胎移植与慢速冷冻胚胎移植相比未增加不良新生儿结局风险,从慢速冷冻转向玻璃化冷冻进行胚胎冷冻保存是令人安心的。
  • 作者指出,当前发现仅适用于卵裂期冷冻胚胎移植,不适用于原核期或囊胚期胚胎移植。

局限性

  • 尽管分析调整了多个重要混杂因素,但医院数据集不包含其他潜在混杂因素,如妇女病史和孕期产科结局,无法进行调整。
  • 当前发现仅适用于卵裂期冷冻胚胎移植,不适用于原核期或囊胚期胚胎移植。
  • 未来仍需研究玻璃化冷冻方法对子代健康结局的长期影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is embryo vitrification associated with a higher risk of adverse perinatal outcomes than slow-freezing? SUMMARY ANSWER: Embryo vitrification was not associated with increased risks of adverse perinatal outcomes of pre-term birth (PTB), low birthweight (LBW), small for gestational age (SGA), large for gestational age (LGA) and macrosomia, as compared to slow-freezing. WHAT IS KNOWN ALREADY: Vitrification is becoming a widely adopted technology for embryo cryopreservation with higher embryo survival rate and live birth rate than the slow-freezing technique. However, limited data are currently available on risks of adverse perinatal outcomes following vitrification as compared to that of slow-freezing. The impact of vitrification on perinatal outcomes remains further to be elucidated. STUDY DESIGN, SIZE, DURATION: Six large reproductive medical centers in Guangdong province, Southeast of China, took part in this multicenter retrospective cohort study. Cohorts of 3199 live born singletons after Day 3 frozen-thawed embryo transfer (FET) cycles with either vitrification or slow-freezing between January 2011 and December 2015 were included in the study. Each patient only contributed one cycle per cohort and vanishing twins were excluded. Propensity score (PS) matching was used to control for potential confounding factors. PARTICIPANTS/MATERIALS, SETTING, METHODS: All live-born singletons following either a vitrified or a slow-frozen cleavage FET cycle during the period from 2011 to 2015 were analyzed. Perinatal outcomes of PTB, LBW, macrosomia, SGA and LGA were compared. The vitrified and slow-frozen cohorts were matched by propensity scores with a 1:1 ratio accounting for potential confounding factors associated with perinatal outcomes. These variables included baseline demographics (maternal age, BMI, education level, parity, type of infertility and cause of infertility), as well as IVF characteristics (insemination method, endometrial preparation protocol and embryo cryopreservation duration). MAIN RESULTS AND THE ROLE OF CHANCE: A total of 2858 cases from vitrified embryo transfer (ET) and 341 babies from the slow-freezing group were included. After PS matching, 297 pairs of newborns were generated for comparison. The median gestational age was 39 weeks for both cohorts and the birthweights were comparable (3187.7 ± 502.1 g in the vitrified group vs. 3224.6 ± 483.6 in the slow-freezing group, P>0.05). There were no significant differences between the two groups on the incidence of PTB (5.4% vs. 7.7%), LBW (6.7% vs. 5.7%), macrosomia (5.7% vs. 6.1%), SGA (12.5% vs. 8.4%) and LGA (6.4% vs. 8.1%). Parallel logistic regression analysis indicated that vitrification was non-inferior to slow-freezing method in terms of the occurrence of PTB (OR, 0.68 [95% CI, 0.35, 1.31]), LBW (OR, 1.19[0.61-2.32]), macrosomia (OR, 0.94 [0.48-1.86]), SGA (1.55[0.91-2.64]) and LGA (0.78[0.42-1.45]), P>0.05. Sex-stratified PS matching models with multivariable regression analysis further confirmed that vitrification did not increase the risks of above-mentioned adverse perinatal outcomes in either the male or female infant cohort. LIMITATIONS, REASONS FOR CAUTION: Although the analysis was adjusted for a number of important confounders, the hospital dataset did not contain other potential confounders such as the medical history and obstetrics outcomes of women during pregnancy to allow adjustment. In addition, the current findings are only applicable to cleavage stage FET, but not pronuclei stage or blastocyst stage ET. WIDER IMPLICATIONS OF THE FINDINGS: Vitrified ET, in comparison with slow-frozen ET, was not associated with increased risks of adverse neonatal outcomes. With its superiority on live birth rates and non-inferiority on safety perinatal outcomes, transition from slow-freezing to the use of vitrification for embryo cryopreservation is reassuring. Nonetheless, future research is needed for the long-term effects of vitrification method on offspring's health outcomes. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the National Key Research and Development Program (2016YFC100205), Guangzhou Science and Technology Project (201804020087), Guangdong Province Science and Technology Project (2016A020218008) and Guangdong Provincial Key Laboratory of Reproductive Medicine (2012A061400003). The authors have no conflicts of interest to declare.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Gu F, Li S, Zheng L, et al. Perinatal outcomes of singletons following vitrification versus slow-freezing of embryos: a multicenter cohort study using propensity score analysis. Hum Reprod. 2019. PMID: 31407797. doi:10.1093/humrep/dez095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。